期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

重视缺血性卒中后血脂调控的分层管理 被引量：1

Stressing Stratification Management on Lipid Control after Ischemic Stroke
在线阅读 下载PDF
导出
摘要 　　脂质代谢障碍是缺血性卒中的独立危险因素[1],2006年发表的积极降低胆固醇水平预防卒中(SPARCL)研究证实了他汀类药物在卒中二级预防中的作用[2].由于缺血性卒中后有效的预防手段不多,现有经过循证医学验证的方法更应受到临床医师的重视.……
作者 张微微
机构地区 北京军区总医院神经内科
出处 《中国卒中杂志》 2007年第4期295-296,共2页 Chinese Journal of Stroke
关键词 卒中 缺血性 他汀 血脂异常 分层 治疗
分类号 R743.3 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献6

  • 1[1]Baigent C,Keech A,Kearney PM,et al.Efficacy and safety of cholesterol-lowering treatment:prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins[J].Lancet,2005,366:1267-1278.
  • 2[2]Amarenco P,Bogousslavsky J,Callahan A,et al.High-dose atorvastatin after stroke or transient ischemic attack[J].N Engl J Med,2006,355:549-559.
  • 3[3]Chenq AY,Leiter LA.Inplications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel Ⅲ guidelines[J].Curr Opin Cardiol,2004,110:227-239.
  • 4他汀类药物预防缺血性卒中/短暂性脑缺血发作的专家建议[J].中华内科杂志,2007,46(1):81-83. 被引量：124
  • 5[5]Amarenco P,Labreuche J,Lavallee P,et al.Statins in stroke prevention and carotid atherosclerosis:systematic review and up-to-date meta-analysis[J].Stroke,2004,35:2902-2909.
  • 6[6]Law MR,Wald N,Rudnicka AR,et al.Quantifying effect of statins on low density lipoprotein cholesterol,ischaemic heart disease,and stroke:systematic review and meta-analysis[J].BM J,2003,326:1407-1408.

二级参考文献14

  • 1Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP)Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults ( Adult Treatment Panel Ⅲ). JAMA,2001,285 : 2486-2497.
  • 2Baigent C, Keech A, Keamey PM, et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet,2005,366 : 1267-1278.
  • 3Sacco RL, Adams R, Albers G,et al. Guidelines for prevention of stroke in patients with ischemic stroke or transiem ischemic attack: a statemem for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology Affirms the value of this guideline. Circulation ,2006,113 : e409-e449.
  • 4Cannon CP,Steinberg BA, Murphy SA,et al. Meta-analysis of cardiovascular outcomes trials comparing intensive versus moderate statin therapy. J Am Coil Cardiol, 2006,48:438-445.
  • 5Amarenco P, Bogousslavsky J, Callahan A 3rd, et al. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med, 2006,355:549-559.
  • 6Guyton JR. Benefit versus risk in statin treatment. Am J CardioI, 2006,97 (SA) :95C-97C.
  • 7Gotto AM Jr. Statins, cardiovascular disease, and drug safety. Am J Cardiol,2006,97(8A) :3C-5C.
  • 8Thompson PD, Clarkson PM, Rosenson RS, et al. An assessment of statin safety by muscle experts. Am J Cardiol,2006,97(8A) : 69C-76C.
  • 9Cohen DE, Anania FA, Chalasani N, et al. An assessment of statin safety by hepatologists. Am J Cardiol, 2006,97(8A) :T/C-81C.
  • 10LaRosa JC, Grundy SM, Waters DD, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease. N Engl J Meal,2005,352:1425-1435.

共引文献123

同被引文献5

引证文献1

中国卒中杂志
2007年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部